Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Sex Transm Dis. 2021 Jul 13:10.1097/OLQ.0000000000001509. doi: 10.1097/OLQ.0000000000001509

Table 2.

Characterization of post-azithromycin clinical, Gram stain, and microbiological cure outcomes in men with NGU

Clinical Cure
% (n/N)
Gram stain Cure
% (n/N)
Microbiological Cure
% (n/N)

NGU Pathogen

 CT only 85% (44/52) 73% (38/52) 92% (48/52)
 MG only 50% (8/16) 50% (8/16) 31% (5/16)
 UU only 100% (7/7) 71% (5/7) 100% (7/7)
 IU 67% (24/36) 75% (27/36) N/A
 Mixed 60% (6/10) 60% (6/10) 40% (4/10)
Total 74% (89/121) 69% (84/121) 75% (64/85)